Riskpilot← Back to searchSign inGet full accessSWERECO AS
ASActiveOrg 930700606Smuget 1, 1383 AskerWholesale of pharmaceutical and medical goods · NACE 4646Est. 20230 employees
Revenue 2025
NOK 20,6M
+4% vs 2024
EBITDA margin
13.1%
-27% vs 2024
Equity ratio
13.9%
Financial strength
Net profit 2025
NOK 1,9M
-31% vs 2024
| Revenue | NOK 20,6M | +4% |
| EBITDA | NOK 2,7M | -27% |
| Net profit | NOK 1,9M | -31% |
| Total assets | NOK 6,3M | -1% |
| Equity | NOK 873K | -76% |
| Employees | 0 | — |
Legal name
SWERECO AS
Org number
930700606
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
6. mars 2023
Share capital
NOK 30 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Salg og markedsføring av hjelpemiddelprodukter og medisinsk teknisk utstyr rette mot helsevesen og andre foretak med lignende virksomhet og andre produkter/tjenester som naturlig hører til dette, herunder å delta i andre selskap med lignende virksomhet og kjøp og salg av aksjer eller på annen måte gjøre seg interessert i andre foretak. Selskapet kan også drive med kjøp/drift av fast eiendom.
Address
Smuget 1, 1383 Asker
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 0 | 11 001 | 19 690 | 20 572 |
| Staff expenses | −0 | −0 | −0 | −0 |
| EBITDA | 0 | 1 166 | 3 696 | 2 701 |
| Depreciation & amort. | −0 | −0 | −0 | −0 |
| EBIT | 0 | 1 166 | 3 696 | 2 701 |
| Net financials | 0 | −57 | −104 | −231 |
| Profit before tax | 0 | 1 109 | 3 593 | 2 470 |
| Tax | −0 | 244 | 790 | 543 |
| Net profit | 0 | 865 | 2 802 | 1 926 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 31 | 3 106 | 6 315 | 6 270 |
| Equity | 30 | 895 | 3 697 | 873 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 1 | 2 211 | 2 618 | 5 396 |
| Total debt | 1 | 2 211 | 2 618 | 5 396 |
EBITDA margin
13.1%
This company
15.8%
Market median
-17% vs market
20222025
Equity ratio
13.9%
This company
38.2%
Market median
-64% vs market
20222025
Return on equity
220.5%
This company
18.4%
Market median
+1098% vs market
20222025
Net profit margin
9.4%
This company
8.1%
Market median
+16% vs market
20222025
Asset turnover
3.28×
This company
1.12×
Market median
+193% vs market
20222025
Debt / equity
6.18×
This company
0.62×
Market median
-897% vs market
20222025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-11-24 – 2022-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HG Chief Executive Officer | Chief Executive Officer | 2023 |
| Former (1) | ||
MH Contact Person | Contact Person | 2023 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2023 | |
| Chairman | 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Swereco Ab | Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SWERECO AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hadi Ghane | Chief Executive Officer | 0 companies |
| Mona Hauge | Contact Person | 0 companies |
| Fredrik Gustaf Gordon Larsson | Board of Directors | 0 companies |
| Carl Johan Engelbrekt Lindh | Chairman | 0 companies |